Literature DB >> 11022190

New perspectives for gene therapy in endocrinology.

L Barzon1, R Bonaguro, G Palù, M Boscaro.   

Abstract

Gene therapy for endocrine diseases represents an exciting new type of molecular intervention that may be a curative one. Endocrine disorders that might be treated by gene therapy include monogenic diseases, such as GH deficiency and hypothalamic diabetes insipidus, and multifactorial diseases, such as diabetes mellitus, obesity and cancer. Premises seem promising for endocrine tumours, but many combined approaches of cell and gene therapy are foreseeable also for other endocrine disorders. This review outlines the principles of gene therapy, describes the endocrine disorders that might take advantage of gene transfer approaches, as well as the gene therapy interventions that have already been attempted, their major limitations and the problems that remain to be solved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022190     DOI: 10.1530/eje.0.1430447

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

Review 1.  Technology insight: In vitro culture of spermatogonial stem cells and their potential therapeutic uses.

Authors:  Hiroshi Kubota; Ralph L Brinster
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-02

2.  Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy.

Authors:  Salvatore Alesci; Walter J Ramsey; Stefan R Bornstein; George P Chrousos; Peter J Hornsby; Salvatore Benvenga; Francesco Trimarchi; Monika Ehrhart-Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Sorting of transgenic secretory proteins in rhesus macaque parotid glands after adenovirus-mediated gene transfer.

Authors:  Antonis Voutetakis; Changyu Zheng; Mark Metzger; Ana P Cotrim; Robert E Donahue; Cynthia E Dunbar; Bruce J Baum
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.